文献速递外周动脉疾病

低白蛋白水平与下肢外周动脉疾病术后不良结局的复杂关系

Complex relationship between low albumin level and poor outcome after lower extremity procedures for peripheral artery disease.
PubMed 文献 · J Vasc Surg · 2020-05-26

该研究基于Cerner Health Facts数据库2008-2015年6170例因外周动脉疾病行下肢开放或腔内手术的患者,发现低白蛋白(<3.5 g/dL)与住院死亡、感染、肾衰竭、心脏并发症及住院时间延长相关,多因素分析显示低白蛋白与住院死亡独立强相关(OR 5.23)。

要点

  • 低白蛋白(<3.5 g/dL)与下肢动脉疾病术后住院死亡、感染、肾衰竭和心脏并发症风险升高独立相关。
  • 低白蛋白患者住院时间更长(4.9 vs 2.2天),但校正后30天再入院无显著关联。
  • 多数下肢手术为择期,建议在白蛋白优化后再行择期手术。

核心结论

  • 低术前白蛋白水平与开放和腔内下肢手术后的住院死亡、住院时间延长及严重并发症相关。
  • 因多数下肢手术为择期,应考虑在白蛋白水平优化后再行择期手术。

研究设计与样本

  • 回顾性队列研究,使用Cerner Health Facts数据库(2008-2015)筛选因外周动脉疾病行下肢手术的患者。
  • 共纳入6170例患者,其中4562例(74%)行腔内手术,1608例(26%)行开放手术。

主要发现

  • 多因素分析显示低白蛋白与住院死亡(OR 5.23;95%CI 2.00-13.70)、感染(OR 2.51;95%CI 1.96-3.22)、肾衰竭(OR 2.61;95%CI 1.79-3.79)和心脏并发症(OR 2.59;95%CI 1.69-3.96)独立相关。
  • 多因素校正后,白蛋白水平与30天再入院无显著关联。

关键数值与推荐

  • 低白蛋白定义为<3.5 g/dL。
  • 低白蛋白与住院死亡独立相关(OR 5.23;95%CI 2.00-13.70)。

临床怎么用

  • 术前应检测白蛋白水平,低白蛋白患者(<3.5 g/dL)术后并发症和死亡风险显著升高。
  • 对低白蛋白患者,尤其是择期下肢手术,应考虑推迟手术直至白蛋白优化。
  • 低白蛋白可作为血管外科决策中的风险分层生物标志物。

局限性

  • 回顾性数据库研究,可能存在编码偏倚和未测量混杂因素。
  • 白蛋白与结局的因果关系无法确定,机制复杂(包括抗血小板和炎症功能等),需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: A low albumin level has been associated with poor outcome, including death, in surgical patients. The mechanistic relationship, however, is more complex than simply nutritional. As studies are scant in the vascular population, we sought to examine the association of low albumin level with outcomes in patients undergoing open and endovascular lower extremity procedures for peripheral artery disease. METHODS: Patients with peripheral artery disease undergoing lower extremity procedures (2008-2015) were selected from Cerner Health Facts database (Cerner Corporation, Kansas City, Mo) using International Classification of Diseases, Ninth Revision diagnosis and procedure codes. Age, sex, disease severity, and other comorbidities were captured. Outcomes were identified using codes and encounter data. A χ2analysis and multivariable logistic regression were performed. RESULTS: There were 6170 patients evaluated; 4562 (74%) underwent endovascular procedures and 1608 (26%) underwent open surgery. Low albumin level (<3.5 g/dL) was associated with age ≥80 years (23.1% vs 16.3% normal; P < .0001), black race (21% vs 11.6% normal; P < .0001), tissue loss (38% vs 16.4% normal; P < .0001), and higher Charlson index (mean, 3.1 vs 2.2 in the normal group; P < .0001). Low albumin level was also associated with longer length of stay (4.9 vs 2.2 days normal; P < .0001), higher in-hospital mortality (1.9% vs 0.3% normal; P < .0001), and higher 30-day readmission (15% vs 12.7% normal; P = .02). Multivariable analysis demonstrated that low albumin level was strongly associated with in-hospital death (odds ratio [OR], 5.23; 95% confidence interval [CI], 2.00-13.70), infection (OR, 2.51; 95% CI, 1.96-3.22), renal failure (OR, 2.61; 95% CI, 1.79-3.79), and cardiac complications (OR, 2.59; 95% CI, 1.69-3.96). After multivariable adjustment, there was no association between albumin level and 30-day readmission. CONCLUSIONS: Low preoperative albumin levels are associated with in-hospital death, prolonged length of stay, and severe morbidity after open and endovascular lower extremity procedures. As the majority of lower extremity procedures are elective, serious consideration should be given to deferring elective procedures until albumin levels have been optimized. Because of the pleiotropic effects of albumin, including antiplatelet and inflammatory function, study of this complex relationship may offer insights into how best to integrate this novel biomarker into vascular surgery decision-making.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Bath J, Smith JB, Woodard J, et al. Complex relationship between low albumin level and poor outcome after lower extremity procedures for peripheral artery disease. J Vasc Surg. 2020. PMID: 32470524. doi:10.1016/j.jvs.2020.04.524

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。